Kumar Ravindra
Insider CIK 1586835 · XLRN VP & Chief Scientific Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| XLRN ACCELERON PHARMA INC | S Sale | 2019-09-10 | 2019-09-10 | 3,389 | $45.24 | $153.3K | 86,986 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2019-04-09 | 2019-04-11 | 70 | $44.24 | $3.1K | 90,375 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2019-04-09 | 2019-04-11 | 3,452 | $44.62 | $154.0K | 90,545 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2019-04-09 | 2019-04-11 | 100 | $45.46 | $4.5K | 90,445 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2019-01-25 | 2019-01-29 | 21,500 | — | $0 | 21,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award | 2019-01-25 | 2019-01-29 | 3,850 | — | $0 | 93,997 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2019-01-02 | 2019-01-04 | 3,051 | $43.20 | $131.8K | 90,521 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2019-01-02 | 2019-01-04 | 374 | $43.94 | $16.4K | 90,147 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2019-01-02 | 2019-01-04 | 2,363 | $42.45 | $100.3K | 93,572 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2018-04-03 | 2018-04-04 | 100 | $39.16 | $3.9K | 95,935 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2018-04-03 | 2018-04-04 | 1,103 | $38.34 | $42.3K | 96,035 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2018-03-01 | 2018-03-05 | 26,775 | — | $0 | 26,775 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award | 2018-03-01 | 2018-03-05 | 4,463 | — | $0 | 97,138 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2018-01-02 | 2018-01-04 | 4,300 | $42.41 | $182.4K | 92,675 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2017-09-28 | 2017-09-29 | 6,761 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2017-09-28 | 2017-09-29 | 6,761 | $5.28 | $35.7K | 96,975 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2017-09-13 | 2017-09-14 | 8 | $38.12 | $305 | 90,214 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2017-09-12 | 2017-09-14 | 500 | $39.39 | $19.7K | 90,222 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2017-09-12 | 2017-09-14 | 4,605 | $38.31 | $176.4K | 90,722 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2017-08-08 | 2017-08-09 | 13,065 | — | $0 | 3,624 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2017-08-08 | 2017-08-09 | 13,065 | $24.11 | $315.0K | 108,392 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2017-08-08 | 2017-08-09 | 13,065 | $35.41 | $462.6K | 95,327 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2017-07-05 | 2017-07-07 | 937 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2017-07-05 | 2017-07-07 | 937 | $7.12 | $6.7K | 96,264 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2017-07-05 | 2017-07-07 | 937 | $32.00 | $30.0K | 95,327 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2017-03-02 | 2017-03-14 | 41,300 | — | $0 | 41,300 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award | 2017-03-02 | 2017-03-14 | 6,900 | — | $0 | 95,327 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2017-01-04 | 2017-01-06 | 359 | $26.81 | $9.6K | 90,068 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2017-01-04 | 2017-01-06 | 1,641 | $27.60 | $45.3K | 88,427 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2016-12-22 | 2016-12-23 | 10,000 | — | $0 | 6,761 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2016-12-22 | 2016-12-23 | 4,561 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2016-12-22 | 2016-12-23 | 4,561 | $3.88 | $17.7K | 90,427 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2016-12-22 | 2016-12-23 | 10,000 | $5.28 | $52.8K | 85,866 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2016-10-10 | 2016-10-11 | 4,182 | — | $0 | 937 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2016-10-10 | 2016-10-11 | 8,101 | — | $0 | 16,689 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2016-10-10 | 2016-10-11 | 4,550 | — | $0 | 31,850 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2016-10-10 | 2016-10-11 | 16,833 | $34.14 | $574.7K | 75,866 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2016-10-10 | 2016-10-11 | 4,550 | $27.97 | $127.3K | 92,699 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2016-10-10 | 2016-10-11 | 8,101 | $24.11 | $195.3K | 88,149 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2016-10-10 | 2016-10-11 | 4,182 | $7.12 | $29.8K | 80,048 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2016-10-07 | 2016-10-11 | 954 | — | $0 | 4,561 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2016-10-07 | 2016-10-11 | 2,381 | — | $0 | 5,119 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2016-10-07 | 2016-10-11 | 1,115 | — | $0 | 16,761 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2016-10-07 | 2016-10-11 | 10,984 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2016-10-07 | 2016-10-11 | 4,210 | — | $0 | 24,790 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2016-10-07 | 2016-10-11 | 1,115 | $5.28 | $5.9K | 88,919 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2016-10-07 | 2016-10-11 | 10,984 | $5.28 | $58.0K | 87,804 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2016-10-07 | 2016-10-11 | 2,381 | $7.12 | $17.0K | 91,300 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2016-10-07 | 2016-10-11 | 4,210 | $24.11 | $101.5K | 95,510 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2016-10-07 | 2016-10-11 | 19,616 | $33.37 | $654.6K | 75,894 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2016-10-07 | 2016-10-11 | 954 | $3.88 | $3.7K | 76,820 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2016-10-07 | 2016-10-11 | 28 | $34.00 | $952 | 75,866 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2016-10-06 | 2016-10-11 | 7,124 | — | $0 | 17,876 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2016-10-06 | 2016-10-11 | 1,561 | $34.98 | $54.6K | 75,866 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2016-10-06 | 2016-10-11 | 14,448 | $34.31 | $495.7K | 77,427 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2016-10-06 | 2016-10-11 | 7,124 | $5.28 | $37.6K | 91,875 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2016-03-03 | 2016-03-07 | 36,400 | — | $0 | 36,400 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award | 2016-03-03 | 2016-03-07 | 6,000 | — | $0 | 84,751 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2016-02-25 | 2016-02-29 | 8,000 | — | $0 | 5,515 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2016-02-25 | 2016-02-29 | 8,000 | $3.88 | $31.0K | 78,751 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2015-10-19 | 2015-10-21 | 2,300 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2015-10-19 | 2015-10-21 | 5,516 | — | $0 | 10,984 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2015-10-19 | 2015-10-21 | 6,250 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2015-10-19 | 2015-10-21 | 2,300 | $1.80 | $4.1K | 58,985 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2015-10-19 | 2015-10-21 | 6,250 | $5.08 | $31.8K | 65,235 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2015-10-19 | 2015-10-21 | 5,516 | $5.28 | $29.1K | 70,751 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2015-09-15 | 2015-09-16 | 11,485 | — | $0 | 13,515 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-09-15 | 2015-09-16 | 33,000 | $35.00 | $1.16M | 56,685 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2015-09-15 | 2015-09-16 | 11,485 | $3.88 | $44.6K | 89,685 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award | 2015-09-09 | 2015-09-11 | 40,000 | — | $0 | 78,200 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2015-04-28 | 2015-04-30 | 5,000 | — | $0 | 2,300 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2015-04-28 | 2015-04-30 | 5,000 | $1.80 | $9.0K | 38,200 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2015-03-04 | 2015-03-06 | 3,500 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2015-03-04 | 2015-03-06 | 500 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-03-04 | 2015-03-06 | 2,086 | $40.56 | $84.6K | 36,614 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2015-03-04 | 2015-03-06 | 3,500 | $5.88 | $20.6K | 38,700 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-03-04 | 2015-03-06 | 1,614 | $41.22 | $66.5K | 35,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-03-04 | 2015-03-06 | 300 | $42.06 | $12.6K | 34,700 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-03-04 | 2015-03-06 | 1,034 | $40.62 | $42.0K | 33,666 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-03-04 | 2015-03-06 | 366 | $41.09 | $15.0K | 33,300 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-03-04 | 2015-03-06 | 100 | $42.04 | $4.2K | 33,200 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2015-03-04 | 2015-03-06 | 500 | $5.88 | $2.9K | 35,200 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2015-02-02 | 2015-02-04 | 4,000 | — | $0 | 500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-02-02 | 2015-02-04 | 300 | $39.46 | $11.8K | 34,700 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-02-02 | 2015-02-04 | 1,435 | $39.13 | $56.2K | 36,200 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-02-02 | 2015-02-04 | 2,565 | $38.39 | $98.5K | 37,635 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2015-02-02 | 2015-02-04 | 4,000 | $5.88 | $23.5K | 40,200 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-02-02 | 2015-02-04 | 1,200 | $38.56 | $46.3K | 35,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-01-12 | 2015-01-13 | 1,100 | $41.06 | $45.2K | 36,200 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-01-12 | 2015-01-13 | 400 | $40.09 | $16.0K | 37,300 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2015-01-08 | 2015-01-09 | 41,000 | — | $0 | 41,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2015-01-02 | 2015-01-05 | 4,000 | — | $0 | 4,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-01-02 | 2015-01-05 | 3,600 | $38.36 | $138.1K | 38,100 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2015-01-02 | 2015-01-05 | 400 | $39.37 | $15.7K | 37,700 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2015-01-02 | 2015-01-05 | 4,000 | $5.88 | $23.5K | 41,700 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2014-12-19 | 2014-12-19 | 5,825 | — | $0 | 7,300 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2014-12-19 | 2014-12-19 | 3,985 | — | $0 | 0 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2014-12-19 | 2014-12-19 | 5,825 | $1.80 | $10.5K | 37,700 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2014-12-19 | 2014-12-19 | 3,985 | $0.92 | $3.7K | 31,875 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2014-12-01 | 2014-12-02 | 4,000 | — | $0 | 8,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-12-01 | 2014-12-02 | 1,100 | $37.44 | $41.2K | 27,890 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-12-01 | 2014-12-02 | 1,000 | $36.10 | $36.1K | 28,990 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-12-01 | 2014-12-02 | 1,900 | $34.87 | $66.3K | 29,990 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2014-12-01 | 2014-12-02 | 4,000 | $5.88 | $23.5K | 31,890 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2014-11-13 | 2014-11-14 | 5,000 | — | $0 | 1,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2014-11-13 | 2014-11-14 | 5,000 | — | $0 | 16,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-11-13 | 2014-11-14 | 12,000 | $35.00 | $420.0K | 27,890 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2014-11-13 | 2014-11-14 | 5,000 | $5.28 | $26.4K | 39,890 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2014-11-13 | 2014-11-14 | 5,000 | $5.88 | $29.4K | 34,890 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2014-11-12 | 2014-11-14 | 4,000 | — | $0 | 14,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2014-11-12 | 2014-11-14 | 4,000 | $5.88 | $23.5K | 33,890 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-11-12 | 2014-11-14 | 1,600 | $32.46 | $51.9K | 32,290 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-11-12 | 2014-11-14 | 2,400 | $33.56 | $80.5K | 29,890 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2014-10-01 | 2014-10-01 | 4,000 | — | $0 | 18,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-10-01 | 2014-10-01 | 3,392 | $29.57 | $100.3K | 30,498 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-10-01 | 2014-10-01 | 608 | $30.36 | $18.5K | 29,890 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2014-10-01 | 2014-10-01 | 4,000 | $5.88 | $23.5K | 33,890 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2014-09-30 | 2014-10-01 | 3,500 | — | $0 | 21,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2014-09-30 | 2014-10-01 | 1,500 | — | $0 | 6,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-09-30 | 2014-10-01 | 7,000 | $30.00 | $210.0K | 29,890 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2014-09-30 | 2014-10-01 | 1,500 | $5.88 | $8.8K | 33,390 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2014-09-30 | 2014-10-01 | 3,500 | $5.28 | $18.5K | 36,890 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2014-09-02 | 2014-12-02 | 2,000 | — | $0 | 20,500 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2014-09-02 | 2014-09-04 | 2,000 | — | $0 | 8,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-09-02 | 2014-09-04 | 2,000 | $26.40 | $52.8K | 31,890 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2014-09-02 | 2014-09-04 | 2,000 | $5.88 | $11.8K | 33,890 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2014-08-14 | 2014-08-15 | 5,000 | $5.88 | $29.4K | 10,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2014-08-14 | 2014-08-15 | 5,000 | $5.88 | $29.4K | 38,890 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-08-14 | 2014-08-15 | 7,000 | $30.00 | $210.0K | 31,890 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-08-14 | 2014-08-15 | 2,000 | $29.85 | $59.7K | 33,890 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-07-01 | 2014-07-02 | 2,000 | $34.10 | $68.2K | 35,890 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2014-06-20 | 2014-06-24 | 5,000 | — | $0 | 15,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2014-06-20 | 2014-06-24 | 5,000 | $5.88 | $29.4K | 44,890 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-06-20 | 2014-06-24 | 7,000 | $35.00 | $245.0K | 37,890 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-06-02 | 2014-06-04 | 2,000 | $29.72 | $59.4K | 39,890 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise deriv | 2014-05-19 | 2014-05-21 | 5,000 | — | $0 | 20,000 | SEC↗ |
| XLRN ACCELERON PHARMA INC | M Exercise | 2014-05-19 | 2014-05-21 | 5,000 | $5.88 | $29.4K | 50,890 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-05-19 | 2014-05-21 | 500 | $32.13 | $16.1K | 43,890 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-05-19 | 2014-05-21 | 1,800 | $31.51 | $56.7K | 42,090 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-05-19 | 2014-05-21 | 6,500 | $31.23 | $203.0K | 44,390 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-05-19 | 2014-05-21 | 200 | $32.27 | $6.5K | 41,890 | SEC↗ |
| XLRN ACCELERON PHARMA INC | S Sale | 2014-04-22 | 2014-04-24 | 2,000 | $35.86 | $71.7K | 45,890 | SEC↗ |
| XLRN ACCELERON PHARMA INC | A Award deriv | 2013-12-05 | 2013-12-09 | 29,000 | — | $0 | 29,000 | SEC↗ |